D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 19,505 142 World Ranking 12948 National Ranking 260

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Gene

His main research concerns Alzheimer's disease, Pathology, Cerebrospinal fluid, Internal medicine and Dementia. Niels Andreasen has researched Alzheimer's disease in several fields, including Central nervous system disease, Degenerative disease, Gerontology, Geriatrics and Apolipoprotein E. His biological study spans a wide range of topics, including Total tau, Tau protein, Pathogenesis, Cognitive decline and Biomarker.

His Tau protein research is multidisciplinary, relying on both Endocrinology, Elisa assay and Frontotemporal dementia. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Placebo and Neurology. His work in Dementia covers topics such as Psychiatry which are related to areas like Nootropic Agents, Memantine and Intensive care medicine.

His most cited work include:

  • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (893 citations)
  • Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease (543 citations)
  • Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice (494 citations)

What are the main themes of his work throughout his whole career to date?

Niels Andreasen spends much of his time researching Internal medicine, Cerebrospinal fluid, Alzheimer's disease, Pathology and Disease. His Internal medicine study deals with Endocrinology intersecting with Amyloid beta. The study incorporates disciplines such as Tau protein, Dementia, Frontotemporal dementia, Biomarker and Neurology in addition to Cerebrospinal fluid.

The Dementia study which covers Psychiatry that intersects with Intensive care medicine. His Alzheimer's disease research integrates issues from Genetics, Apolipoprotein E and Central nervous system disease, Degenerative disease. His research investigates the connection between Disease and topics such as Immunology that intersect with issues in Proteomics.

He most often published in these fields:

  • Internal medicine (46.28%)
  • Cerebrospinal fluid (42.55%)
  • Alzheimer's disease (42.55%)

What were the highlights of his more recent work (between 2013-2019)?

  • Internal medicine (46.28%)
  • Disease (32.98%)
  • Dementia (25.53%)

In recent papers he was focusing on the following fields of study:

Niels Andreasen focuses on Internal medicine, Disease, Dementia, Cerebrospinal fluid and Pathology. Niels Andreasen interconnects Cerebral glucose metabolism, Endocrinology and Oncology in the investigation of issues within Internal medicine. The concepts of his Disease study are interwoven with issues in Psychiatry, Clinical trial and Intensive care medicine.

The various areas that he examines in his Dementia study include Tau protein, Neuroscience and Pathogenesis. His Default mode network research extends to the thematically linked field of Pathology. His Alzheimer's disease research is multidisciplinary, incorporating perspectives in Glycoprotein, Apolipoprotein E, Drug and Amyloid.

Between 2013 and 2019, his most popular works were:

  • Clinical trials and late-stage drug development for Alzheimer's disease : an appraisal from 1984 to 2014 (409 citations)
  • Clinical trials and late-stage drug development for Alzheimer's disease : an appraisal from 1984 to 2014 (409 citations)
  • Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease (385 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Alzheimer's disease

The scientist’s investigation covers issues in Dementia, Internal medicine, Disease, Alzheimer's disease and Pathology. His study of Cognitive decline is a part of Dementia. His Disease research incorporates elements of Psychiatry, Clinical trial and Intensive care medicine.

His research integrates issues of Memantine, Drug development, Drug and Nootropic Agents in his study of Intensive care medicine. In general Pathology study, his work on Cerebrospinal fluid often relates to the realm of Glial fibrillary acidic protein, thereby connecting several areas of interest. Niels Andreasen combines subjects such as Endocrinology, Cholinergic and Implant with his study of Tolerability.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
JAMA (2009)

1247 Citations

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

Niels Andreasen;Lennart Minthon;Pia Davidsson;Eugeen Vanmechelen.
JAMA Neurology (2001)

696 Citations

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease

Niels Andreasen;Camilla Hesse;Pia Davidsson;Lennart Minthon.
JAMA Neurology (1999)

679 Citations

Clinical trials and late-stage drug development for Alzheimer's disease : an appraisal from 1984 to 2014

Lon S. Schneider;Francesca Mangialasche;Francesca Mangialasche;Niels Andreasen;Niels Andreasen;Howard Feldman.
Journal of Internal Medicine (2014)

623 Citations

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Harald Hampel;Katharina Buerger;Raymond Zinkowski;Stefan J. Teipel.
Archives of General Psychiatry (2004)

508 Citations

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

E Vanmechelen;H Vanderstichele;P Davidsson;E Van Kerschaver.
Neuroscience Letters (2000)

495 Citations

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S Honig;Bruno Vellas;Michael M Woodward;Mercè Boada.
The New England Journal of Medicine (2018)

477 Citations

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

Camilla Hesse;Lars Rosengren;Niels Andreasen;Pia Davidsson.
Neuroscience Letters (2001)

464 Citations

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

Magnus Sjögren;Hugo Vanderstichele;Hans Ågren;Olof Zachrisson.
Clinical Chemistry (2001)

458 Citations

Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology

Annika Olsson;Hugo Vanderstichele;Niels Andreasen;Geert De Meyer.
Clinical Chemistry (2005)

450 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Niels Andreasen

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 818

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 788

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 157

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 155

Oskar Hansson

Oskar Hansson

Lund University

Publications: 143

Niklas Mattsson

Niklas Mattsson

Lund University

Publications: 139

Charlotte E. Teunissen

Charlotte E. Teunissen

Vrije Universiteit Amsterdam

Publications: 123

Jens Wiltfang

Jens Wiltfang

University of Göttingen

Publications: 112

Lennart Minthon

Lennart Minthon

Lund University

Publications: 110

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 107

Leslie M. Shaw

Leslie M. Shaw

University of Pennsylvania

Publications: 103

Wiesje M. van der Flier

Wiesje M. van der Flier

Vrije Universiteit Amsterdam

Publications: 93

Pieter Jelle Visser

Pieter Jelle Visser

Maastricht University

Publications: 90

Ulf Andreasson

Ulf Andreasson

University of Gothenburg

Publications: 83

Dag Aarsland

Dag Aarsland

King's College London

Publications: 83

Anders Wallin

Anders Wallin

University of Gothenburg

Publications: 81

Trending Scientists

Radu-Emil Precup

Radu-Emil Precup

Polytechnic University of Timişoara

Mark Dredze

Mark Dredze

Johns Hopkins University

Thomas B. Rauchfuss

Thomas B. Rauchfuss

University of Illinois at Urbana-Champaign

Nigel D. Browning

Nigel D. Browning

University of Liverpool

Sylvain Glémin

Sylvain Glémin

Uppsala University

Thierry Rabilloud

Thierry Rabilloud

Grenoble Alpes University

Robert E. Hodson

Robert E. Hodson

University of Georgia

Julian Lewis

Julian Lewis

Cancer Research UK London Research Institute

Rainer G. Ulrich

Rainer G. Ulrich

Friedrich-Loeffler-Institut

Shigeto Watanabe

Shigeto Watanabe

Hokkaido Information University

Paul H. Warren

Paul H. Warren

University of California, Los Angeles

Rohit Mathur

Rohit Mathur

Research Triangle Park Foundation

Michael E. R. Nicholls

Michael E. R. Nicholls

Flinders University

Detlef Zillikens

Detlef Zillikens

University of Lübeck

Derald Wing Sue

Derald Wing Sue

Columbia University

Daniel P. Judge

Daniel P. Judge

Medical University of South Carolina

Something went wrong. Please try again later.